Accurate, continuous CO2 monitoring that helps pulmonology and sleep lab teams tailor NIV therapy to each patient’s evolving needs.

Non-invasive ventilation (NIV) for hypercapnic respiratory conditions has grown substantially, supported by strong evidence across patient groups. To achieve the best outcomes, ensure effective support, and enable quick detection of issues, settings should be personalized, ventilation monitored continuously, and patients reassessed regularly.

This clinical impact summary provides an overview of the evidence showing how transcutaneous CO2 monitoring can support your clinical practice:

  • Increasing global burden: Hypercapnic respiratory disorders such as COPD and OHS create a significant and increasing health-economic burden.

  • Improved outcomes with well-titrated NIV: NIV helps restore daytime and nocturnal CO2 levels and can reduce mortality and shorten hospital stays.

  • Regular reassessment and titration: Continuous CO2 monitoring allows clinicians to assess and titrate NIV settings to effectively tailor treatment to the individual patient.

  • Better accuracy and feasibility: Transcutaneous CO2 monitoring has demonstrated higher accuracy than end-tidal CO2 and better feasibility than both end-tidal monitoring and arterial blood gases.

  • Guideline-supported practice: European clinical practice guidelines include transcutaneous CO2 monitoring for NIV titration and management.

transcutaneous monitoring in the NICU: clinical utility and impact

Non-invasive ventilation (NIV) for hypercapnic respiratory conditions has grown substantially, supported by strong evidence across patient groups. To achieve the best outcomes, ensure effective support, and enable quick detection of issues, settings should be personalized, ventilation monitored continuously, and patients reassessed regularly.

This clinical impact summary provides an overview of the evidence showing how transcutaneous CO2 monitoring can support your clinical practice:

  • Increasing global burden: Hypercapnic respiratory disorders such as COPD and OHS create a significant and increasing health-economic burden.

  • Improved outcomes with well-titrated NIV: NIV helps restore daytime and nocturnal CO2 levels and can reduce mortality and shorten hospital stays.

  • Regular reassessment and titration: Continuous CO2 monitoring allows clinicians to assess and titrate NIV settings to effectively tailor treatment to the individual patient.

  • Better accuracy and feasibility: Transcutaneous CO2 monitoring has demonstrated higher accuracy than end-tidal CO2 and better feasibility than both end-tidal monitoring and arterial blood gases.

  • Guideline-supported practice: European clinical practice guidelines include transcutaneous CO2 monitoring for NIV titration and management.

Meet the tCOM+

Developed with care, designed for confidence.

The tCOM+ offers continuous monitoring of tcPCO2, SpO2, and PR with a sleek new look and feel. This latest model includes significant software advances that improve workflow for providers, while continuing to support reduced blood draws and proactive ventilator management across care areas.

tCOM-device-angled
Stay up-to-date with Sentec

Related Posts

  • Sentec Article

    Transcutaneous CO2 Monitoring in the NICU: A Q&A with the Clinical Team at Klinikum Karlsruhe, Germany

    In this interview, Dr. med. Frauke Riedel, a specialist in neonatology and pediatric intensive care, and Kerstin Thees, NICU ward manager and pediatric nurse, share their clinical experience with transcutaneous CO2 monitoring (tcPCO2) in the hospital’s neonatal intensive care unit (NICU). 

  • Whitepaper

    Bilanciare la protezione di cervello e polmoni nelle TIN con il monitoraggio transcutaneo della CO2

    Questo white paper esplora il modo in cui i medici trovano il giusto equilibrio tra protezione del cervello e dei polmoni fragili e in via di sviluppo dei neonati prematuri nelle TIN.

  • Whitepaper

    Protéger le cerveau et les poumons en USIN grâce à la surveillance transcutanée du CO2

    Ce livre blanc étudie comment les cliniciens parviennent à concilier la protection du cerveau et des poumons fragiles et en développement des nourrissons prématurés en USIN.